Company news

Keymed Biosciences, Inc. news in 2024

Keymed Biosciences, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Keymed Biosciences Announces Approval Of Stapokibart For The Treatment Of Chronic Rhinosinusitis With Nasal Polyposis

December 24, 2024